Five Strategies to Attract Investors

The biopharmaceutical industry posted record levels of VC funding in 2020 and 2021, presenting a clear opportunity for small and emerging biotechs to advance their innovations. Whether a company seeks to out-license an asset, commercialize an asset, or position itself for acquisition, success often depends on early investments. Importantly, securing investment drives the development of new treatments for the patients who need them most.

How can biotech companies plan their early development strategy to best position themselves for investment? Using both data from our investor survey and direct experience helping biotech clients, we identified five strategies that can help raise funds in the early stages of development.

Download the report by completing the short form below: